The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Enhanced CD138 peptide-specific cytotoxic T lymphocyte activities against breast, colon and pancreatic cancers in combination with pembrolizumab (anti-PD1).

Jooeun  Bae

Patents, Royalties, Other Intellectual Property - OncoPep

Teru  Hideshima

No Relationships to Disclose

Yu-Tzu  Tai

No Relationships to Disclose

Nikhil C.  Munshi

Patents, Royalties, Other Intellectual Property - OncoPep

Kenneth Carl  Anderson

Stock and Other Ownership Interests  - C4 Therapeutics; OncoPep

Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen Oncology; Millennium; Sanofi

Patents, Royalties, Other Intellectual Property - C4 Therapeutics; Oncopep